Seeking Alpha

Nektar Therapeutics (NKTR)

We currently have no Breaking News on this stock.
Company Description
Nektar Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops a pipeline of drug candidates that utilizes its PEGylation and polymer conjugate technology platforms that are designed to develop molecular entities.
Sector: Healthcare
Industry: Biotechnology
Country: United States